BalkEChungMRamanGTatsioniAChewPIpSDeVineDLauJ. B vitamins and berries and age-related neurodegenerative disorders. Evidence Report/Technology Assessment No. 134. (Prepared by Tufts-New England Medical Center Evidence-based Practice Center under Contract No. 290-02-0022). AHRQ Publication No. 06-E008. Rockville, MD: Agency for Healthcare Research and Quality. April 2006. Available at: http://www.ahrq.gov/downloads/pub/evidence/pdf/berry/berry.pdf. Accessed 18 March 2008.
2.
DeijenJBSlumpEWouters-WesselingWDe GrootCPGalleEPasH. Nutritional intake and daily functioning of psychogeriatric nursing home residents. J Nutr Health Aging2003;7:242–6.
3.
MizrahiEHJacobsenDWDebanneSMTraoreFLernerAJFriedlandRPPetotGJ. Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging. J Nutr Health Aging2003;7:160–5.
4.
BryanJCalvaresiEHughesD. Short-term folate, vitamin B12 or vitamin B6 supplementation slightly affects memory performance but not mood in women of various ages. J Nutr2002;132:1345–56.
5.
GoodwinJSGoodwinJMGarryPJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA1983;249:2917–21.
6.
LeeLKangSALeeHOLeeBHParkJSKimJHJungIKParkYJLeeJE. Relationships between dietary intake and cognitive function level in Korean elderly people. Public Health2001;115:133–8.
7.
RenvallMJSpindlerAARamsdellJWPaskvanM. Nutritional status of free-living Alzheimer's patients. Am J Med Sci1989;298:20–7.
8.
RequejoAMOrtegaRMRoblesFNaviaBFaciMAparicioA. Influence of nutrition on cognitive function in a group of elderly, independently living people. Eur J Clin Nutr2003;57(suppl 1):S54–7.
9.
MorrisMCEvansDABieniasJLTangneyCCHebertLEScherrPASchneiderJA. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol2005;62:641–5.
10.
SeshadriSBeiserASelhubJJacquesPFRosenbergIHD'AgostinoRBWilsonPWWolfPA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med2002;346:476–83.
11.
WangHXWahlinABasunHFastbomJWinbladBFratiglioniL. Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology2001;56:1188–94.
12.
BowirratAFriedlandRPFarrerLBaldwinCKorczynA. Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs. J Mol Neurosci2002;1–2:239–45.
13.
ClarkeRHarrisonGRichardsS, Vital Trial Collaborative Group. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med2003;254:67–75.
14.
EngelborghsSVloeberghsEMaertensKMarienPSomersNSymonsAClementFKetelsVSaerensJGoemanJPickutBAVandevivereJDe DeynPP. Correlations between cognitive, behavioural and psychological findings and levels of vitamin B12 and folate in patients with dementia. Int J Geriatr Psychiatry2004;19:365–70.
15.
StuerenburgHJMueller-ThomsenTMethnerA. Vitamin B12 plasma concentrations in Alzheimer disease. Neuroendocrinol Lett2004;25:176–7.
16.
WhyteEMMulsantBHButtersMAQayyumMTowersASweetRAKlunkWWisniewskiSDeKoskyST. Cognitive and behavioral correlates of low vitamin B12 levels in elderly patients with progressive dementia. Am J Geriatr Psychiatry2002;10:321–7.
17.
AssantachaiPYamwongPChongsuphaijaisiddhiT. Relationships of vitamin B1, B12, folate and the cognitive ability of the Thai rural elderly. J Med Assoc Thai1997;80:700–5.
18.
ScileppiKPBlassJPBakerHG. Circulating vitamins in Alzheimer's dementia as compared with other dementias. J Am Geriatr Soc1984;32:709–11.
19.
CoimbraCGJunqueiraVB. High doses of riboflavin and the elimination of dietary red meat promote the recovery of some motor functions in Parkinson's disease patients. Braz J Med Biol Res2003;36:1409–17.
20.
WoitallaDKuhnWMullerT. MTHFR C677T polymorphism, folic acid and hyperhomocysteinemia in levodopa treated patients with Parkinson's disease. J Neural Transm Suppl2004;68:15–20.
21.
Andersen-RanbergKVasegaardLJeuneB. Dementia is not inevitable: A population-based study of Danish centenarians. J Gerontol B Psychol Sci Soc Sci2001;56:P152–9.
22.
AnelloGGueant-RodriguezRMBoscoPGueantJLRomanoANamourBSpadaRCaraciFPourieGDavalJLFerriR. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport2004;15:859–61.
23.
ArgyriadouSVlachonikolisIMelisopoulouHKatachanakisKLionisC. In what extent anemia coexists with cognitive impairment in elderly: A cross-sectional study in Greece. BMC Fam Pract2001;2:5.
24.
CacabelosRFernandez-NovoaLCorzoLPichelVLombardiVKubotaY. Genomics and phenotypic profiles in dementia: Implications for pharmacological treatment. Methods Find Exp Clin Pharmacol2004;26:421–44.
25.
ClarkeRSmithADJobstKARefsumHSuttonLUelandPM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol1998; 55:1449–55.
26.
GottfriesJBlennowKLehmannMWReglandBGottfriesCG. One-carbon metabolism and other biochemical correlates of cognitive impairment as visualized by principal component analysis. J Geriatr Psychiatry Neurol2001;14:109–14.
27.
JoostenELesaffreERiezlerRGhekiereVDereymaekerLPelemansWDejaegerE. Is metabolic evidence for vitamin B12 and folate deficiency more frequent in elderly patients with Alzheimer's disease?J Gerontol A Biol Sci Med Sci1997;52:M76–9.
28.
McCaddonABlennowKHudsonPHughesABarberJGrayRDaviesGWilliamsJHDuguidJLloydATandySEverallMCattellHMcCaddonAEllisDPalmerMBogdanovicNGottfriesCGZetterbergHRymoLReglandB. Transcobalamin polymorphism and serum holo-transcobalamin in relation to Alzheimer's disease. Dement Geriatr Cogn Disord2004;71:215–21.
29.
MizrahiEHBowirratAJacobsenDWKorczynADTraoreFPetotGJLernerAJDebanneSMAdunskyADibelloPMFriedlandRP. Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel. J Neurol Sci2004;227:109–13.
30.
NilssonKGustafsonLFaldtRAnderssonABrattstromLLindgrenAIsraelssonBHultbergB. Hyperhomocysteinaemia—a common finding in a psychogeriatric population. Eur J Clin Invest1996;26:853–9.
31.
PostiglioneAMilanGRuoccoAGallottaGGuiottoGDi MinnoG. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study. Gerontology2001;47:324–9.
32.
QuadriPFragiacomoCPezzatiRZandaEForloniGTettamantiMLuccaU. Homocysteine, folate, and vitamin B12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr2004;80:114–22.
33.
RavagliaGFortiPMaioliFMuscariASacchettiLArnoneGNativioVTalericoTMarianiE. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am J Clin Nutr2003;77:668–73.
34.
RefsumHSmithAD. Low vitamin B12 status in confirmed Alzheimer's disease as revealed by serum holotranscobalamin. J Neurol Neurosurg Psychiatry2003;74:959–61.
35.
ReglandBGottfriesCGOrelandLSvennerholmL. Low B12 levels related to high activity of platelet MAO in patients with dementia disorders. A retrospective study. Acta Psychiatr Scand1988;78:451–7.
36.
ReligaDStyczynskaMPeplonskaBGabryelewiczTPfefferAChodakowskaMLuczywekEWasiakBStepienKGolebiowskiMWinbladBBarcikowskaM. Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord2003;16:64–70.
37.
ShaharAFeiglinLShaharDRLevySSeligsohnU. High prevalence and impact of subnormal serum vitamin B12 levels in Israeli elders admitted to a geriatric hospital. J Nutr Health Aging2001;5:124–7.
38.
TripathiMSheshadriSPadmaMVJainSMeheshwariMCBehariM. Serum cobalamin levels in dementias. Neurol India2001;49:284–6.
39.
SnowdonDATullyCLSmithCDRileyKPMarkesberyWR. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: Findings from the Nun study. Am J Clin Nutr2000;71:993–8.
40.
MillerJWGreenRMungasDMReedBRJagustWJ. Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology2002;58:1471–5.
41.
NaggaKRajaniRMardhEBorchKMardhSMarcussonJ. Cobalamin, folate, methylmalonic acid, homocysteine, and gastritis markers in dementia. Dement Geriatr Cogn Disord2003;16:269–75.
42.
NilssonSETakkinenSTrydingNEvrinPEBergSMcClearnGJohanssonB. Association of biochemical values with morbidity in the elderly: A population-based Swedish study of persons aged 82 or more years. Scand J Clin Lab Invest2003;63:457–66.
43.
SerotJMChristmannDDubostTBeneMCFaureGC. CSF-folate levels are decreased in late-onset AD patients. J Neural Transm2001;108:93–9.
44.
MaxwellCJHoganDBEblyEM. Serum folate levels and subsequent adverse cerebrovascular outcomes in elderly persons. Dement Geriatr Cogn Disord2002;13:225–34.
45.
StewartRAsonganyiBSherwoodR. Plasma homocysteine and cognitive impairment in an older British African-Caribbean population. J Am Geriatr Soc2002;50:1227–32.
46.
JonesSSmallBJFratiglioniLBackmanL. Predictors of cognitive change from preclinical to clinical Alzheimer's disease. Brain Cogn2002;49:210–3.
47.
TuckerKLQiaoNScottTRosenbergISpiroA3rd. High homocysteine and low B vitamins predict cognitive decline in aging men: The Veterans Affairs Normative Aging Study. Am J Clin Nutr2005;82:627–35.
48.
RiggsKMSpiroAIIITuckerKRushD. Relations of vitamin B12, vitamin B6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr1996;63:306–14.
49.
KadoDKarlamanglaAHuangMTroenARoweJSelhubJSeemanT. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med2005;118:161–7.
50.
AbyadA. Prevalence of vitamin B12 deficiency among demented patients and cognitive recovery with cobalamin replacement. J Nutr Health Aging2002;6:254–60.
51.
CarmelRGottPSWatersCHCairoKGreenRBondareffWDeGiorgioCMCummingsJLJacobsenDWBuckwalterG. The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol1995;54:245–53.
52.
HvasAMJuulSLauritzenLNexoEEllegaardJ. No effect of vitamin B12 treatment on cognitive function and depression: A randomized placebo controlled study. J Affect Disord2004;81:269–73.
53.
IkedaTYamamotoKTakahashiKKakuYUchiyamaMSugiyamaKYamadaM. Treatment of Alzheimer-type dementia with intravenous mecobalamin. Clin Ther1992;14:426–37.
54.
ItoTYamaderaHItoRSuzukiHAsayamaKEndoS. Effects of vitamin B12 on bright light on cognitive and sleep-wake rhythm in Alzheimer-type dementia. Psychiatry Clin Neurosci2001;55:281–2.
55.
KralVASolyomLEnescoHLedwidgeB. Relationship of vitamin B12 and folic acid to memory function. Biol Psychiatry1970;2:19–26.
56.
KwokTTangCWooJLaiWKLawLKPangCP. Randomized trial of the effect of supplementation on the cognitive function of older people with subnormal cobalamin levels. Int J Geriatr Psychiatry1998;13:611–6.
57.
MartinDCFrancisJProtetchJHuffFJ. Time dependency of cognitive recovery with cobalamin replacement: Report of a pilot study. J Am Geriatr Soc1992;40:168–72.
58.
MitsuyamaYKogohH. Serum and cerebrospinal fluid vitamin B12 levels in demented patients with CH3-B12 treatment—preliminary study. Jpn J Psychiatry Neurol1988;42:65–71.
59.
SealECMetzJFlickerLMelnyJ. A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations. J Am Geriatr Soc2002;50:146–51.
60.
TeunisseSBollenAEvan GoolWAWalstraGJ. Dementia and subnormal levels of vitamin B12: Effects of replacement therapy on dementia. J Neurol1996;243:522–9.
61.
van AsseltDZPasmanJWvan LierHJVingerhoetsDMPoelsPJKuinYBlomHJHoefnagelsWH. Cobalamin supplementation improves cognitive and cerebral function in older, cobalamin-deficient persons. J Gerontol A Biol Sci Med Sci2001;56:M775–9.
62.
SommerBRHoffALCostaM. Folic acid supplementation in dementia: A preliminary report. J Geriatr Psychiatry Neurol2003;16:156–9.
63.
FioravantiMFerrarioEMassaiaMCappaGRivoltaGGrossiEBuckleyAE. Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits. Arch Gerontol Geriatrics1997;26:1–13.
64.
McGeerPLZeldowiczLMcGeerEG. A clinical trial of folic acid in Parkinson's disease. Can Med Assoc J1972;106:145–6.
65.
RapinJRLePoncinMGrebylJ. Blood folates deficiencies and cognitive functions in aging. Trends Biomed Gerontol1988;1:315–23.
66.
DurgaJvan BoxtelMPJSchoutenEGJollesJKokFJVerhoefP. The effect of 3-year folic acid supplementation on cognitive function. A randomized controlled trial. Haematologica Reports2005;1(3):1 (abstract S001).
67.
LewerinCMatousekMSteenGJohanssonBSteenBNilsson-EhleH. Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: A placebo-controlled randomized study. Am J Clin Nutr2005;81:1155–62.
68.
ShawDMMacsweeneyDAJohnsonALO'KeeffeRNaidooDMacleodDMJogSPreeceJMCrowleyJM. Folate and amine metabolites in senile dementia: A combined trial and biochemical study. Psychol Med1971;1:166–71.
69.
AisenPSEgelkoSAndrewsHDiaz-ArrastiaRWeinerMDeCarliCJagustWMillerJWGreenRBellKSanoM. A pilot study of vitamins to lower plasma homocysteine levels in Alzheimer disease. Am J Geriatr Psychiatry2003;11:246–9.
70.
LehmannMReglandBBlennowKGottfriesCG. Vitamin B12–B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment. Dement Geriatr Cogn Disord2003;16:145–50.
71.
NilssonKGustafsonLHultbergB. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry2001;16:609–14.